Cargando…

The KAG motif of HLA-DRB1 (β71, β74, β86) predicts seroconversion and development of type 1 diabetes

BACKGROUND: HLA-DR4, a common antigen of HLA-DRB1, has multiple subtypes that are strongly associated with risk of type 1 diabetes (T1D); however, some are risk neutral or resistant. The pathobiological mechanism of HLA-DR4 subtypes remains to be elucidated. METHODS: We used a population-based case-...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Lue Ping, Papadopoulos, George K, Lybrand, Terry P., Moustakas, Antonis K., Bondinas, George P., Carlsson, Annelie, Larsson, Helena Elding, Ludvigsson, Johnny, Marcus, Claude, Persson, Martina, Samuelsson, Ulf, Wang, Ruihan, Pyo, Chul-Woo, Nelson, Wyatt C., Geraghty, Daniel E., Rich, Stephen S., Lernmark, Åke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220560/
https://www.ncbi.nlm.nih.gov/pubmed/34153873
http://dx.doi.org/10.1016/j.ebiom.2021.103431
_version_ 1783711168928415744
author Zhao, Lue Ping
Papadopoulos, George K
Lybrand, Terry P.
Moustakas, Antonis K.
Bondinas, George P.
Carlsson, Annelie
Larsson, Helena Elding
Ludvigsson, Johnny
Marcus, Claude
Persson, Martina
Samuelsson, Ulf
Wang, Ruihan
Pyo, Chul-Woo
Nelson, Wyatt C.
Geraghty, Daniel E.
Rich, Stephen S.
Lernmark, Åke
author_facet Zhao, Lue Ping
Papadopoulos, George K
Lybrand, Terry P.
Moustakas, Antonis K.
Bondinas, George P.
Carlsson, Annelie
Larsson, Helena Elding
Ludvigsson, Johnny
Marcus, Claude
Persson, Martina
Samuelsson, Ulf
Wang, Ruihan
Pyo, Chul-Woo
Nelson, Wyatt C.
Geraghty, Daniel E.
Rich, Stephen S.
Lernmark, Åke
author_sort Zhao, Lue Ping
collection PubMed
description BACKGROUND: HLA-DR4, a common antigen of HLA-DRB1, has multiple subtypes that are strongly associated with risk of type 1 diabetes (T1D); however, some are risk neutral or resistant. The pathobiological mechanism of HLA-DR4 subtypes remains to be elucidated. METHODS: We used a population-based case-control study of T1D (962 patients and 636 controls) to decipher genetic associations of HLA-DR4 subtypes and specific residues with susceptibility to T1D. Using a birth cohort of 7865 children with periodically measured islet autoantibodies (GADA, IAA or IA-2A), we proposed to validate discovered genetic associations with a totally different study design and time-to-seroconversions prior to clinical onset of T1D. A novel analytic strategy hierarchically organized the HLA-DRB1 alleles by sequence similarity and identified critical amino acid residues by minimizing local genomic architecture and higher-order interactions. FINDINGS: Three amino acid residues of HLA-DRB1 (β71, β74, β86) were found to be predictive of T1D risk in the population-based study. The “KAG” motif, corresponding to HLA-DRB1×04:01, was most strongly associated with T1D risk ([O]dds [R]atio=3.64, p = 3.19 × 10(−64)). Three less frequent motifs (“EAV”, OR = 2.55, p = 0.025; “RAG”, OR = 1.93, p = 0.043; and “RAV”, OR = 1.56, p = 0.003) were associated with T1D risk, while two motifs (“REG” and “REV”) were equally protective (OR = 0.11, p = 4.23 × 10(−4)). In an independent birth cohort of HLA-DR3 and HLA-DR4 subjects, those having the “KAG” motif had increased risk for time-to-seroconversion (Hazard Ratio = 1.74, p = 6.51 × 10(−14)) after adjusting potential confounders. INTERPRETATIONS: DNA sequence variation in HLA-DRB1 at positions β71, β74, and β86 are non-conservative (β74 A→E, β71 E vs K vs R and β86 G vs V). They result in substantial differences in peptide antigen anchor pocket preferences at p1, p4 and potentially neighboring regions such as pocket p7. Differential peptide antigen binding is likely to be affected. These sequence substitutions may account for most of the HLA-DR4 contribution to T1D risk as illustrated in two HLA-peptide model complexes of the T1D autoantigens preproinsulin and GAD65. FUNDING: National Institute of Diabetes and Digestive and Kidney Diseases and the Swedish Child Diabetes Foundation and the Swedish Research Council.
format Online
Article
Text
id pubmed-8220560
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-82205602021-06-29 The KAG motif of HLA-DRB1 (β71, β74, β86) predicts seroconversion and development of type 1 diabetes Zhao, Lue Ping Papadopoulos, George K Lybrand, Terry P. Moustakas, Antonis K. Bondinas, George P. Carlsson, Annelie Larsson, Helena Elding Ludvigsson, Johnny Marcus, Claude Persson, Martina Samuelsson, Ulf Wang, Ruihan Pyo, Chul-Woo Nelson, Wyatt C. Geraghty, Daniel E. Rich, Stephen S. Lernmark, Åke EBioMedicine Research Paper BACKGROUND: HLA-DR4, a common antigen of HLA-DRB1, has multiple subtypes that are strongly associated with risk of type 1 diabetes (T1D); however, some are risk neutral or resistant. The pathobiological mechanism of HLA-DR4 subtypes remains to be elucidated. METHODS: We used a population-based case-control study of T1D (962 patients and 636 controls) to decipher genetic associations of HLA-DR4 subtypes and specific residues with susceptibility to T1D. Using a birth cohort of 7865 children with periodically measured islet autoantibodies (GADA, IAA or IA-2A), we proposed to validate discovered genetic associations with a totally different study design and time-to-seroconversions prior to clinical onset of T1D. A novel analytic strategy hierarchically organized the HLA-DRB1 alleles by sequence similarity and identified critical amino acid residues by minimizing local genomic architecture and higher-order interactions. FINDINGS: Three amino acid residues of HLA-DRB1 (β71, β74, β86) were found to be predictive of T1D risk in the population-based study. The “KAG” motif, corresponding to HLA-DRB1×04:01, was most strongly associated with T1D risk ([O]dds [R]atio=3.64, p = 3.19 × 10(−64)). Three less frequent motifs (“EAV”, OR = 2.55, p = 0.025; “RAG”, OR = 1.93, p = 0.043; and “RAV”, OR = 1.56, p = 0.003) were associated with T1D risk, while two motifs (“REG” and “REV”) were equally protective (OR = 0.11, p = 4.23 × 10(−4)). In an independent birth cohort of HLA-DR3 and HLA-DR4 subjects, those having the “KAG” motif had increased risk for time-to-seroconversion (Hazard Ratio = 1.74, p = 6.51 × 10(−14)) after adjusting potential confounders. INTERPRETATIONS: DNA sequence variation in HLA-DRB1 at positions β71, β74, and β86 are non-conservative (β74 A→E, β71 E vs K vs R and β86 G vs V). They result in substantial differences in peptide antigen anchor pocket preferences at p1, p4 and potentially neighboring regions such as pocket p7. Differential peptide antigen binding is likely to be affected. These sequence substitutions may account for most of the HLA-DR4 contribution to T1D risk as illustrated in two HLA-peptide model complexes of the T1D autoantigens preproinsulin and GAD65. FUNDING: National Institute of Diabetes and Digestive and Kidney Diseases and the Swedish Child Diabetes Foundation and the Swedish Research Council. Elsevier 2021-06-19 /pmc/articles/PMC8220560/ /pubmed/34153873 http://dx.doi.org/10.1016/j.ebiom.2021.103431 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Research Paper
Zhao, Lue Ping
Papadopoulos, George K
Lybrand, Terry P.
Moustakas, Antonis K.
Bondinas, George P.
Carlsson, Annelie
Larsson, Helena Elding
Ludvigsson, Johnny
Marcus, Claude
Persson, Martina
Samuelsson, Ulf
Wang, Ruihan
Pyo, Chul-Woo
Nelson, Wyatt C.
Geraghty, Daniel E.
Rich, Stephen S.
Lernmark, Åke
The KAG motif of HLA-DRB1 (β71, β74, β86) predicts seroconversion and development of type 1 diabetes
title The KAG motif of HLA-DRB1 (β71, β74, β86) predicts seroconversion and development of type 1 diabetes
title_full The KAG motif of HLA-DRB1 (β71, β74, β86) predicts seroconversion and development of type 1 diabetes
title_fullStr The KAG motif of HLA-DRB1 (β71, β74, β86) predicts seroconversion and development of type 1 diabetes
title_full_unstemmed The KAG motif of HLA-DRB1 (β71, β74, β86) predicts seroconversion and development of type 1 diabetes
title_short The KAG motif of HLA-DRB1 (β71, β74, β86) predicts seroconversion and development of type 1 diabetes
title_sort kag motif of hla-drb1 (β71, β74, β86) predicts seroconversion and development of type 1 diabetes
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220560/
https://www.ncbi.nlm.nih.gov/pubmed/34153873
http://dx.doi.org/10.1016/j.ebiom.2021.103431
work_keys_str_mv AT zhaolueping thekagmotifofhladrb1b71b74b86predictsseroconversionanddevelopmentoftype1diabetes
AT papadopoulosgeorgek thekagmotifofhladrb1b71b74b86predictsseroconversionanddevelopmentoftype1diabetes
AT lybrandterryp thekagmotifofhladrb1b71b74b86predictsseroconversionanddevelopmentoftype1diabetes
AT moustakasantonisk thekagmotifofhladrb1b71b74b86predictsseroconversionanddevelopmentoftype1diabetes
AT bondinasgeorgep thekagmotifofhladrb1b71b74b86predictsseroconversionanddevelopmentoftype1diabetes
AT carlssonannelie thekagmotifofhladrb1b71b74b86predictsseroconversionanddevelopmentoftype1diabetes
AT larssonhelenaelding thekagmotifofhladrb1b71b74b86predictsseroconversionanddevelopmentoftype1diabetes
AT ludvigssonjohnny thekagmotifofhladrb1b71b74b86predictsseroconversionanddevelopmentoftype1diabetes
AT marcusclaude thekagmotifofhladrb1b71b74b86predictsseroconversionanddevelopmentoftype1diabetes
AT perssonmartina thekagmotifofhladrb1b71b74b86predictsseroconversionanddevelopmentoftype1diabetes
AT samuelssonulf thekagmotifofhladrb1b71b74b86predictsseroconversionanddevelopmentoftype1diabetes
AT wangruihan thekagmotifofhladrb1b71b74b86predictsseroconversionanddevelopmentoftype1diabetes
AT pyochulwoo thekagmotifofhladrb1b71b74b86predictsseroconversionanddevelopmentoftype1diabetes
AT nelsonwyattc thekagmotifofhladrb1b71b74b86predictsseroconversionanddevelopmentoftype1diabetes
AT geraghtydaniele thekagmotifofhladrb1b71b74b86predictsseroconversionanddevelopmentoftype1diabetes
AT richstephens thekagmotifofhladrb1b71b74b86predictsseroconversionanddevelopmentoftype1diabetes
AT lernmarkake thekagmotifofhladrb1b71b74b86predictsseroconversionanddevelopmentoftype1diabetes
AT thekagmotifofhladrb1b71b74b86predictsseroconversionanddevelopmentoftype1diabetes
AT zhaolueping kagmotifofhladrb1b71b74b86predictsseroconversionanddevelopmentoftype1diabetes
AT papadopoulosgeorgek kagmotifofhladrb1b71b74b86predictsseroconversionanddevelopmentoftype1diabetes
AT lybrandterryp kagmotifofhladrb1b71b74b86predictsseroconversionanddevelopmentoftype1diabetes
AT moustakasantonisk kagmotifofhladrb1b71b74b86predictsseroconversionanddevelopmentoftype1diabetes
AT bondinasgeorgep kagmotifofhladrb1b71b74b86predictsseroconversionanddevelopmentoftype1diabetes
AT carlssonannelie kagmotifofhladrb1b71b74b86predictsseroconversionanddevelopmentoftype1diabetes
AT larssonhelenaelding kagmotifofhladrb1b71b74b86predictsseroconversionanddevelopmentoftype1diabetes
AT ludvigssonjohnny kagmotifofhladrb1b71b74b86predictsseroconversionanddevelopmentoftype1diabetes
AT marcusclaude kagmotifofhladrb1b71b74b86predictsseroconversionanddevelopmentoftype1diabetes
AT perssonmartina kagmotifofhladrb1b71b74b86predictsseroconversionanddevelopmentoftype1diabetes
AT samuelssonulf kagmotifofhladrb1b71b74b86predictsseroconversionanddevelopmentoftype1diabetes
AT wangruihan kagmotifofhladrb1b71b74b86predictsseroconversionanddevelopmentoftype1diabetes
AT pyochulwoo kagmotifofhladrb1b71b74b86predictsseroconversionanddevelopmentoftype1diabetes
AT nelsonwyattc kagmotifofhladrb1b71b74b86predictsseroconversionanddevelopmentoftype1diabetes
AT geraghtydaniele kagmotifofhladrb1b71b74b86predictsseroconversionanddevelopmentoftype1diabetes
AT richstephens kagmotifofhladrb1b71b74b86predictsseroconversionanddevelopmentoftype1diabetes
AT lernmarkake kagmotifofhladrb1b71b74b86predictsseroconversionanddevelopmentoftype1diabetes
AT kagmotifofhladrb1b71b74b86predictsseroconversionanddevelopmentoftype1diabetes